Jose R. Arribas-Lopez
Experienced in Osteosclerosis Autosomal Dominant

Jose R. Arribas-Lopez

Madrid, MD, ES 
Experienced in Osteosclerosis Autosomal Dominant
Madrid, MD, ES 
OverviewLocationsClinical Research

Overview

Jose Arribas-Lopez practices in Madrid, Spain. Mr. Arribas-Lopez is rated as an Experienced expert by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are HIV/AIDS, COVID-19, Severe Acute Respiratory Syndrome (SARS), AIDS Dementia Complex, and Vasectomy.

His clinical research consists of co-authoring 220 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Osteosclerosis Autosomal Dominant.

Gender
Male

Locations

Madrid, MD, Spain
Other Locations
La Paz, MD, Spain
Castellana, MD 28046, Spain
La Paz, CN, Spain
Barcelona, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19
Randomized Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19
Enrollment Status: Completed
Publish Date: March 06, 2024
Intervention Type: Drug
Study Drugs: Emtricitabine, Tenofovir Disoproxil Fumarate, Baricitinib, Dexamethasone
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
A Phase II, Single-center, Double-blind, Randomized Placebo-controlled Trial to Explore the Efficacy and Safety of Intravenous Melatonin in Patients With COVID-19 Admitted to the Intensive Care Unit (MelCOVID Study)
A Phase II, Single-center, Double-blind, Randomized Placebo-controlled Trial to Explore the Efficacy and Safety of Intravenous Melatonin in Patients With COVID-19 Admitted to the Intensive Care Unit (MelCOVID Study)
Enrollment Status: Completed
Publish Date: March 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.
Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.
Enrollment Status: Unknown
Publish Date: July 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

220 Total Publications

Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection.
Prognostic value of blood epigenetic biomarkers of aging in persons with well controlled HIV infection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Arribas-Lopez's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile